Valve replacement for failing aortic bioprosthetic valves
Part of Heart & circulation clinical trials.
This trial studies a new “valve-in-valve” procedure to treat a failing aortic bioprosthetic valve. It may help people improve blood flow through the heart valve and reduce valve-related problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a failing bioprosthetic (tissue) valve in the heart’s aortic position
- Your current aortic valve leak and/or blockage is at least moderate
- The old valve size fits a specific range (about 18.5 to 28.5 mm inside)
- Your heart symptoms are at least moderate (NYHA class II or higher)
- Your heart team believes you are low to intermediate risk for this procedure
- You agree to the study and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new version of a heart valve (SAPIEN X4) placed without open-heart surgery. It's for people with severe aortic stenosis who have symptoms like shortness of breath or chest pain.
This study tests a new way to replace your narrowed aortic valve without open-heart surgery, using a device called SAPIEN 3. It is designed for people with a specific valve shape (Type 0 bicuspid) who have severe symptoms.
This trial tests a new replacement heart valve for people with severe aortic stenosis (narrowing of the aortic valve). The valve is placed without open-heart surgery. It aims to be safer and work better for patients who are at intermediate or higher risk for surgery.
This study is testing a new heart valve called the SAPIEN 3 Ultra RESILIA valve for people with severe aortic stenosis. Researchers want to see how well it works and how safe it is over 10 years after a minimally invasive valve replacement procedure called TAVI.
This trial studies whether a new transcatheter aortic valve (SAPIEN X4) is safe and works well in people whose previously implanted aortic valve is now failing. It may help reduce valve symptoms in higher-surgery-risk patients who are not good candidates for open-heart valve replacement.
This trial tests a new, less invasive replacement valve for people whose mitral heart valve is failing. The goal is to improve blood flow and reduce symptoms like shortness of breath without the need for major open-heart surgery.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.